Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients

Benoit Wallaert, Nicolas Masson, Olivier Le Rouzic, Baptiste Chéhère, Lidwine Wémeau-Stervinou, Jean-Marie Grosbois
ERJ Open Research 2018 4: 00167-2017; DOI: 10.1183/23120541.00167-2017
Benoit Wallaert
1Univ. Lille, CHU Lille, Centre de Référence des Maladies Pulmonaires Rares, Service de Pneumologie Immunologie et Allergologie, Hôpital Calmette, Lille, France
2Institut Pasteur de Lille, Lille, France
5Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Masson
1Univ. Lille, CHU Lille, Centre de Référence des Maladies Pulmonaires Rares, Service de Pneumologie Immunologie et Allergologie, Hôpital Calmette, Lille, France
5Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Le Rouzic
1Univ. Lille, CHU Lille, Centre de Référence des Maladies Pulmonaires Rares, Service de Pneumologie Immunologie et Allergologie, Hôpital Calmette, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Le Rouzic
Baptiste Chéhère
3Univ. Lille, EA 7369 - URePSSS - Multidisciplinary Research Unit in Sport Health Society, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lidwine Wémeau-Stervinou
1Univ. Lille, CHU Lille, Centre de Référence des Maladies Pulmonaires Rares, Service de Pneumologie Immunologie et Allergologie, Hôpital Calmette, Lille, France
2Institut Pasteur de Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marie Grosbois
4FormAction Santé, Pérenchies, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Fibrotic idiopathic interstitial pneumonia patients derived benefit from a pulmonary rehabilitation programme in terms of exercise tolerance, anxiety, depression and quality of life without increasing their daily life physical activity http://ow.ly/WV7U30kgNkU

To the Editor:

According to the international consensus statement of 2011, idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP) are classified as fibrotic idiopathic interstitial pneumonia (f-IIP) of unknown aetiology [1]. f-IIP patients display persistent and significant dyspnoea, exercise intolerance and poor health-related quality of life [2]. f-IIP is also associated with a marked reduction in daily life physical activity (DLPA) [3], which is related to morbidity and mortality in many chronic diseases, including f-IIP [4–6].

Pulmonary rehabilitation (PR) is a validated and widely used method to improve exercise tolerance in patients with chronic respiratory diseases, including interstitial lung diseases (ILDs) [7]. In this patient population, improvements have been demonstrated in the distance covered during the 6-min walk test, peak oxygen uptake during exercise [7, 8], and associated dyspnoea and quality of life scores [7]. However, it is not known whether PR improves DLPA of patients with f-IIP. To address this knowledge gap, we report here the results of an observational, retrospective, routine clinical practice study of home-based PR management of all f-IIP patients referred to us by their pulmonologists over a 4-year period.

Between December 2011 and December 2015, 176 Caucasian patients with a diagnosis of f-IIP were referred to our reference centre for rare pulmonary diseases for a diagnosis and medical decision based on multidisciplinary discussion with radiologists and pathologists. The inclusion criteria were 1) a diagnosis of IPF or NSIP according to the international consensus guidelines [9], and 2) no acute exacerbation in the 3 months preceding enrolment. Of the 176 patients, 86 (male:female ratio 2:3) gave written informed consent to participate in our home-based PR programme. Approval for the use of these data was provided by the Institutional Review Board of the French Learned Society for Pulmonology (CEPRO 2011-039).

Forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were measured using spirometry with a Jaeger-Masterlab cabin (Vyaire medical, Hoechberg, Germany), and single-breath diffusing capacity of the lung for carbon monoxide (DLCO; units of mL CO·min−1·mmHg−1) was measured and corrected for haemoglobin concentration. Values are expressed as percentages of the predicted normal values. Subjects were equipped with a physical activity monitor (SenseWear Pro Armband with SenseWear software version 6.1; BodyMedia Inc., Pittsburgh, PA, USA) and instructed to wear the device continuously (except while showering or bathing) for five consecutive days, of which two were to be weekend days, as previously described [3]. DLPA was assessed by measuring four parameters: the number of steps per day, the time (min·day−1) spent in activities above an estimated energy expenditure of 2.5 metabolic equivalents (METs), the total energy expenditure above 2.5 METs (kcal·day−1), and the total daily energy expenditure (kcal·day−1). Exercise tolerance was evaluated at home using a 6-min stepper test (6MST), as previously reported [10]. During the 6MST, arterial oxygen saturation and heart rate were measured continuously and the total number of steps was recorded. The Hospital Anxiety and Depression Scale (HADS) questionnaire was administered to identify and quantify anxiety and depression. For both subscales, a score of ≥8 (scale 0–21) is indicative of clinically relevant symptoms. Quality of life was assessed using the Visual Simplified Respiratory Questionnaire (VSRQ).

Home-based PR was carried out for eight consecutive weeks, as previously described [11]. In brief, a qualified exercise specialist performed a training diagnostic assessment and initiated the programme in the patient's home to ensure full understanding. Thereafter, the specialist visited once a week for 8 weeks. The exercise training lasted for 30–45 min a day and included endurance training on a cycle ergometer (Domyos VM 630; Decathlon, Villeneuve d'Ascq, France) or stepper, muscle-strengthening exercises using weights and elastic resistance bands, activities of daily living, walking, and learning to climb stairs. A cycle ergometer or stepper was installed in the patients' homes for use during the PR programme. The patients learnt to recognise their dyspnoea threshold and were encouraged to perform this daily exercise programme independently. Therapeutic education, psychosocial support and motivational communication to encourage health-related behaviour changes and self-management were also implemented. Compliance with the PR programme was evaluated weekly by a team member by questioning the patient about DLPA, adherence to treatments, independent exercises, nutrition, and other factors, and implementing exercise re-training, if required. The 6MST, DLPA, VSRQ, and HADS scores were evaluated before and immediately after completion of the 8-week PR programme.

Statistical analysis was performed using the SAS statistical package, version 8 (SAS Institute Inc., Cary, NC, USA) and Prism 5 (GraphPad Software Inc., La Jolla, CA, USA). Normal distribution was verified with the Kolmogorov–Smirnov test. Quantitative variables are expressed as mean±sd, and differences between means were compared by Student's t-test. A p-value ≤0.05 was considered statistically significant.

The PR programme was completed by 72 (84%) of the 86 patients. The remaining 14 patients were unable to perform exercise training because of a severe change in their condition (n=6), bronchial infection (n=4), lower back pain and joint pain (n=2), and non-acceptance of the armband (n=2). Of the final 72 patients (IPF n=35 and f-NSIP n=37), the mean±sd values were: age 64.3±10 years, body mass index 26.3±4.8 kg·m−2, FVC 71±19%, FEV1 70.4±20.2%, and DLCO 37±12%. As expected, exercise tolerance (6MST) and quality of life (VSRQ) improved significantly after PR, as did the HADS scores, particularly the anxiety score (table 1). However, the four parameters of DLPA were not significantly different before and after PR.

View this table:
  • View inline
  • View popup
TABLE 1

Effects of pulmonary rehabilitation (PR) on daily life physical activity, exercise tolerance, anxiety, depression and quality of life in fibrotic idiopathic interstitial pneumonia patients

The present study has three main findings: 1) PR significantly improved exercise tolerance and quality of life, as expected; 2) surprisingly, DLPA measures were not changed after PR; and 3) interestingly, PR was associated with a decrease in both anxiety and depression. Our data are consistent with previous studies demonstrating that PR improves exercise tolerance, symptoms and quality of life in patients with chronic respiratory diseases, including ILDs such as f-IIP [7, 12]. However, this is the first investigation of the relationship between PR and DLPA.

Objective gains in physical activity after PR has been studied in chronic obstructive pulmonary disease patients and did not show significant improvement, despite evidence of increased exercise tolerance [13, 14]. We previously reported that DLPA was significantly impaired in f-IIP patients, as measured using a physical activity monitor [3]; however, to our knowledge, this is the first study evaluating the influence of PR on DLPA using objective parameters obtained with a physical activity monitor. Previous studies that evaluated physical activity of f-IIP patients before and after PR used the International Physical Activity Questionnaire to estimate physical activity levels [12, 15]. Although the results suggested that small benefits had been obtained, questionnaires are not authentic measures of actual DLPA. It is unclear why DLPA did not change despite the improvement in exercise tolerance. One possibility is that the shorter duration of DLPA >2.5 METs after PR was compensated by a longer duration of DLPA <2.5 METs. Such a scenario would be consistent with the observed lack of significant change in total energy expenditure (kcal·day−1). We also cannot exclude the possibility that the patients might have “rewarded” themselves by taking more leisure time at the end of PR programme; however, this is speculation. The PR programme included a personalised education programme geared towards helping and supporting the patients to adopt good health-related behaviour. Given that the patients' environment did not change at the end of the programme, except for removal of the weekly supervised session, we might have expected the patients to maintain the same level of physical activity immediately after completion of the PR programme. The fact that this was not observed suggests that simply increasing the patient's exercise capacity through a PR programme does not mean that they will subsequently take advantage of it in their daily life.

Anxiety and depression are higher in f-IIP patients than in the general population [16]. In a recent study, symptoms of depression and anxiety were present in 25.9% and 21.4%, respectively, of 112 patients with IPF [17]. The causes of psychological distress include dyspnoea, comorbidity, loss of independence, feelings of social isolation and inadequate sleep [2, 16]. Our results are in agreement with the findings of Harrison et al. [18] that PR is associated with a significant improvement of mood, despite the lack of effect on DLPA.

In conclusion, patients with f-IIP derived benefit from a PR programme in terms of exercise tolerance, anxiety, depression and quality of life without increasing their physical activity. Future research should focus on developing PR programmes tailored to promote long-term changes in DLPA.

Footnotes

  • Author contributions: Conception, design, data analysis and interpretation: B. Wallaert, N. Masson, L. Wémeau-Stervinou and J.M. Grosbois; drafting of the manuscript for important intellectual content: B. Wallaert, N. Masson, O. Le Rouzic, B. Chéhère, L. Wémeau-Stervinou, and J.M. Grosbois.

  • Conflict of interest: B. Wallaert reports personal fees, non-financial support and other (advisory board) from Boehringer Ingelheim, personal fees and non-financial support from Vitalaire, personal fees, non-financial support and other (advisory board) from Roche, outside the submitted work.

  • Conflict of interest: O. Le Rouzic reports personal fees and non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi, Lilly and Novartis; non-financial support from GlaxoSmithKline, MundiPharma, Pfizer, Teva, Santelys Association, Vertex and Vitalaire, all outside the submitted work.

  • Conflict of interest: L. Wémeau-Stervinou reports personal fees, non-financial support and other (advisory board) from Boehringer-Ingelheim, personal fees and non-financial support from Roche, personal fees from Bristol-Myers-Squibb and Janssen-Cilag, outside the submitted work.

  • Conflict of interest: Formaction Santé (J.M. Grosbois) received financial support from Adair, France Oxygène, Homeperf, LVL, Orkyn, Santélys, SOS Oxygène, Sysmed, VitalAire, and the ARS Hauts-de-France for home-based PR programmes.

  • Received December 19, 2017.
  • Accepted May 12, 2018.
  • Copyright ©ERS 2018

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Travis WD,
    2. Costabel U,
    3. Hansell DM, et al.
    An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733–748.
    OpenUrlCrossRefPubMed
  2. ↵
    1. De Vries J,
    2. Drent M
    . Quality of life and health status in interstitial lung diseases. Curr Opin Pulm Med 2006; 12: 354–358.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Wallaert B,
    2. Monge E,
    3. Le Rouzic O, et al.
    Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652–1658.
    OpenUrlPubMed
  4. ↵
    1. Leuchte HH,
    2. Mernitz P,
    3. Baezner C, et al.
    Self-report daily life activity as a prognostic marker of idiopathic pulmonary fibrosis. Respiration 2015; 90: 460–467.
    OpenUrl
    1. Bahmer T,
    2. Kirsten A-M,
    3. Waschki B, et al.
    Clinical correlates of reduced physical activity in idiopathic pulmonary fibrosis. Respiration 2016; 91: 497–502.
    OpenUrl
  5. ↵
    1. Bahmer T,
    2. Kirsten A-M,
    3. Waschki B, et al.
    Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis. BMC Pulm Med 2017; 17: 104.
    OpenUrl
  6. ↵
    1. Dowman L,
    2. Hill CJ,
    3. Holland AE
    . Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014; 10: CD006322.
    OpenUrlPubMed
  7. ↵
    1. Vainshelboim B,
    2. Oliveira J,
    3. Yehoshua L, et al.
    Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration 2014; 88: 378–388.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Raghu G,
    2. Collard HR,
    3. Egan JJ, et al.
    An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788–824.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Grosbois JM,
    2. Riquier C,
    3. Chehere B, et al.
    Six-minute stepper test: a valid clinical exercise tolerance test for COPD patients. Int J Chron Obstruct Pulmon Dis 2016; 11: 657–663.
    OpenUrl
  10. ↵
    1. Grosbois JM,
    2. Gicquello A,
    3. Langlois C, et al.
    Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2015; 10: 2037–2044.
    OpenUrl
  11. ↵
    1. Gaunaurd IA,
    2. Gómez-Marín OW,
    3. Ramos CF, et al.
    Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir Care 2014; 59: 1872–1879.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Pitta F,
    2. Troosters T,
    3. Probst VS, et al.
    Are patients with COPD more active after pulmonary rehabilitation? Chest 2008; 134: 273–280.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Burtin C,
    2. Langer D,
    3. van Remoortel H, et al.
    Physical activity counselling during pulmonary rehabilitation in patients with COPD: a randomised controlled trial. PLoS One 2015; 10: e0144989.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Vainshelboim B,
    2. Fox BD,
    3. Kramer MR, et al.
    Short-term improvement in physical activity and body composition after supervised exercise training program in idiopathic pulmonary fibrosis. Arch Phys Med Rehabil 2016; 97: 788–797.
    OpenUrl
  15. ↵
    1. Holland AE,
    2. Fiore JF,
    3. Bell EC, et al.
    Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology 2014; 19: 1215–1221.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Lee YJ,
    2. Choi SM,
    3. Lee YJ, et al.
    Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. PLoS One 2017; 12: e0184300.
    OpenUrl
  17. ↵
    1. Harrison SL,
    2. Greening NJ,
    3. Williams JEA, et al.
    Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med 2012; 106: 838–844.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
ERJ Open Research: 4 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients
Benoit Wallaert, Nicolas Masson, Olivier Le Rouzic, Baptiste Chéhère, Lidwine Wémeau-Stervinou, Jean-Marie Grosbois
ERJ Open Research Apr 2018, 4 (2) 00167-2017; DOI: 10.1183/23120541.00167-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients
Benoit Wallaert, Nicolas Masson, Olivier Le Rouzic, Baptiste Chéhère, Lidwine Wémeau-Stervinou, Jean-Marie Grosbois
ERJ Open Research Apr 2018, 4 (2) 00167-2017; DOI: 10.1183/23120541.00167-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society